{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:37:40Z","timestamp":1778830660503,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12957-017-1286-1","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T11:56:37Z","timestamp":1513079797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Sarcomatoid hepatocellular carcinoma (SHC): a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Yingying","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/BF00647229","volume":"23","author":"M Kojiro","year":"1989","unstructured":"Kojiro M, Sugihara S, Kakizoe S, Nakashima O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemother Pharmacol. 1989;23:4\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1286_CR2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clbc.2012.01.011","volume":"12","author":"R Nonnis","year":"2012","unstructured":"Nonnis R, Paliogiannis P, Giangrande D, Marras V, Trignano M. Low-grade fibromatosis-like spindle cell metaplastic carcinoma of the breast: a case report and literature review. Clin Breast Cancer. 2012;12:147\u201350.","journal-title":"Clin Breast Cancer"},{"key":"1286_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000339802","volume":"5","author":"D Chrysikos","year":"2012","unstructured":"Chrysikos D, Zagouri F, Sergentanis TN, et al. Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol. 2012;5:347\u201353.","journal-title":"Case Rep Oncol"},{"key":"1286_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3350\/kjhep.2010.16.1.89","volume":"16","author":"JY Seok","year":"2010","unstructured":"Seok JY, Kim YB. Sarcomatoid hepatocellular carcinoma. Korean J Hepatol. 2010;16:89\u201394.","journal-title":"Korean J Hepatol"},{"key":"1286_CR5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.prp.2013.01.005","volume":"209","author":"F Giunchi","year":"2013","unstructured":"Giunchi F, Vasuri F, Baldin P, et al. Primary liver sarcomatous carcinoma: report of two cases and review of the literature. Pathol Res Pract. 2013;209:249\u201354.","journal-title":"Pathol Res Pract"},{"key":"1286_CR6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jhep.2010.11.011","volume":"54","author":"H Marijon","year":"2011","unstructured":"Marijon H, Dokmak S, Paradis V, Zappa M, Bieche I, Bouattour M, Raymond E, Faivre S. Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma. J Hepatol. 2011;54:1073\u20138.","journal-title":"J Hepatol"},{"key":"1286_CR7","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.1007\/BF00647229","volume":"23","author":"M Kojiro","year":"1989","unstructured":"Kojiro M, Sugihara S, Kakizoe S, Nakashima O, Kiyomatsu K. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy. Cancer Chemothe Pharmacolo. 1989;23:s4\u20138.","journal-title":"Cancer Chemothe Pharmacolo"},{"key":"1286_CR8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12072-007-9040-3","volume":"2","author":"K Obara","year":"2008","unstructured":"Obara K, Matsumoto N, Okamoto M, Kobayashi M, Ikeda H, Takahashi H, et al. Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int. 2008;2:116\u201323.","journal-title":"Hepatol Int"},{"key":"1286_CR9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1872-034X.2012.01017.x","volume":"42","author":"C Nakanishi","year":"2012","unstructured":"Nakanishi C, Sato K, Ito Y. Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolization. Hepatol Res. 2012;42:1141\u20135.","journal-title":"Hepatol Res"},{"key":"1286_CR10","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/cncr.10392","volume":"94","author":"WR Jarnagin","year":"2002","unstructured":"Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer. 2002;94:2040\u20136.","journal-title":"Cancer"},{"key":"1286_CR11","first-page":"892","volume":"36","author":"WS Lee","year":"2005","unstructured":"Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today. 2005;36:892\u20137.","journal-title":"Surg Today"},{"key":"1286_CR12","first-page":"191","volume-title":"WHO international histological classification of tumours, pathology and genetics of the tumours of the digestive system","author":"KG Ishak","year":"2000","unstructured":"Ishak KG, Anthony PP, Nicederau C, Nakanuma Y. Mesenchymal tumours of the liver. In: Stanley RH, Lauri AA, editors. WHO international histological classification of tumours, pathology and genetics of the tumours of the digestive system. Lyon: IARC Press; 2000. p. 191\u20138."},{"key":"1286_CR13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial\u2013mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442\u201354.","journal-title":"Nat Rev Cancer"},{"key":"1286_CR14","doi-asserted-by":"crossref","first-page":"e4355","DOI":"10.1371\/journal.pone.0004355","volume":"4","author":"S Battaglia","year":"2009","unstructured":"Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, Zignego AL, Atfi A, Br\u00e9chot C, Bourgeade MF. Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumour suppression to epithelial-mesenchymal transition. PLoS One. 2009;4:e4355.","journal-title":"PLoS One"},{"key":"1286_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/RCT.0b013e3181591ccd","volume":"32","author":"HR Koo","year":"2008","unstructured":"Koo HR, Park MS, Kim MJ, et al. Radiological and clinical features of sarcomatoid hepatocellular carcinoma in 11 cases. J Comput Assist Tomogr. 2008;32:745\u20139.","journal-title":"J Comput Assist Tomogr"},{"key":"1286_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4103\/0377-4929.42504","volume":"51","author":"AD Amarapurkar","year":"2008","unstructured":"Amarapurkar AD, Vibhav, Kim V. Angiogenesis in liver cirrhosis and hepatocellular carcinoma. Indian J Pathol Microbiolo. 2008;51:323\u20138.","journal-title":"Indian J Pathol Microbiolo"},{"key":"1286_CR17","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s11605-007-0393-7","volume":"12","author":"S Hwang","year":"2008","unstructured":"Hwang S, Lee SG, Lee YJ, et al. Prognostic impact of sarcomatous change of hepatocellular carcinoma in patients undergoing liver resection and liver transplantation. J Gastrointest Surg. 2008;12:718\u201324.","journal-title":"J Gastrointest Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-017-1286-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T11:56:39Z","timestamp":1513079799000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-017-1286-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1186\/s12957-017-1286-1","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"219"}}